Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazoloquinolones are potent PARP inhibitors

Pyrazoloquinolones are potent PARP inhibitors

US Patent 8546368 · Granted Oct 1, 2013

Estimated economic value: $59,956,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Macrocyclic MCL-1 inhibitors and methods of use2020
Satellite finding apparatus and satellite finding method2019
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors2017
Pyridopyrimidinone inhibitors of kinases2017
Pyridine CDK9 kinase inhibitors2017
Veliparib in combination with carboplatin and paclitaxel for the treatment of no2017
Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors2016
Tetracyclic CDK9 kinase inhibitors2016
Tetracyclic CDK9 kinase inhibitors2016
Inhibitors of poly(ADP-ribose)polymerase2016
Inhibitors of poly(ADP-ribose)polymerase2016